Recombinant Protein Production News and Research

RSS
HHS' BARDA contract advances development of novel anthrax vaccine, antitoxin

HHS' BARDA contract advances development of novel anthrax vaccine, antitoxin

Bruker releases new amaZon speed ion trap mass spectrometers

Bruker releases new amaZon speed ion trap mass spectrometers

Nature Biotechnology publishes BGI, GT Life Sciences' study on CHO K1 genome

Nature Biotechnology publishes BGI, GT Life Sciences' study on CHO K1 genome

Repligen first quarter total revenue increases 9% to $7,654,000

Repligen first quarter total revenue increases 9% to $7,654,000

Scil Technology receives public research grant for novel rheumatoid arthritis treatments

Scil Technology receives public research grant for novel rheumatoid arthritis treatments

Intrexon, Halozyme partner to develop subcutaneous alpha 1-antitrypsin for A1AT deficiency

Intrexon, Halozyme partner to develop subcutaneous alpha 1-antitrypsin for A1AT deficiency

Initial positive results from ZIOPHARM's ZIN-CTI-001 Phase Ib study against advanced melanoma

Initial positive results from ZIOPHARM's ZIN-CTI-001 Phase Ib study against advanced melanoma

BPD expands existing bioprocess and scale-up laboratory in Poway, CA

BPD expands existing bioprocess and scale-up laboratory in Poway, CA

ZIOPHARM submits IND with FDA for Ad-RTS-IL-12 Phase I study in cancer

ZIOPHARM submits IND with FDA for Ad-RTS-IL-12 Phase I study in cancer

Study shows immune therapy can prevent pregnancy in mammals including humans

Study shows immune therapy can prevent pregnancy in mammals including humans

Immune therapy can control fertility in mammals

Immune therapy can control fertility in mammals

Researchers identify CD19-L protein that facilitates recognition, destruction of leukemia cells

Researchers identify CD19-L protein that facilitates recognition, destruction of leukemia cells

BioMimetic highlights updates on orthopedic and rehabilitation devices during AAOS meeting

BioMimetic highlights updates on orthopedic and rehabilitation devices during AAOS meeting

Baxter fourth quarter net income declines 26% to $423 million

Baxter fourth quarter net income declines 26% to $423 million

Intrexon Corporation, ZIOPHARM enter partnership to develop, commercialize DNA-based therapeutics

Intrexon Corporation, ZIOPHARM enter partnership to develop, commercialize DNA-based therapeutics

GT Life Sciences and BGI complete CHO-K1 genome sequencing

GT Life Sciences and BGI complete CHO-K1 genome sequencing

BioMimetic granted Canadian notice of patent allowance covering rhPDGF-BB platform technology formulations

BioMimetic granted Canadian notice of patent allowance covering rhPDGF-BB platform technology formulations

Fraunhofer USA CMB receives FDA approval to initiate Phase I clinical trial of H5N1 influenza vaccine

Fraunhofer USA CMB receives FDA approval to initiate Phase I clinical trial of H5N1 influenza vaccine

Science and precedent do not support biosimilar approach for plasma protein therapies

Science and precedent do not support biosimilar approach for plasma protein therapies

FDA accepts IND application for vaccine candidate based on iBioLaunch technology platform

FDA accepts IND application for vaccine candidate based on iBioLaunch technology platform